Kilitch Drugs (India) share news and announcements
NSE: KILITCHBSE: 524500Pharmaceuticals & BiotechnologySmall Cap
Last close ₹202.24up ₹0.13 (0.06%)BSE ₹203.50
Share price at the NSE close on 23 Oct 2026. Previous close ₹202.11.
52-week range of traded prices to 23 Oct 2026
₹117.25Low, 30 Mar 2026₹267.90High, 7 Oct 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹707 Cr1,776th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 13 Aug 2026
- 23.5
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 15 May 2026
- 2.5
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 13 Aug 2026
- 12.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 13 Aug 2026
- 8.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 15 May 2026
- 0.32
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 1,44,52347.0% delivered
Kilitch Drugs (India) share news and announcements
492 announcements, routine notices left out, newest first. Page 9 of 10.
Apr 2015
15 Apr · Board meeting
1 Apr · Meeting Updates
As decided in the meeting of the Independent of Directors of the Company held on March 31, 2015, the Independent Directors had: 1. Reviewed the performance of non-independent directors and the Board as a whole and was found satisfactory; 2. Reviewed the performance of the Chairperson of the Company, taking into account the views of executive directors and non-executive directors and was found satisfactory; and 3. Reviewed the quality, quantity and timeliness of flow of information between the Company management and the Board that is necessary for the Board to effectively and reasonably perform their duties was assessed.1 Apr · Board meeting
In the Meeting of the Board of Directors of the Company held on March 31, 2015, it was decided: 1. To appoint Mr. Ramesh Modi as an Independent Director of the Company w.e.f. March 31, 2015. 2. To appoint Mr. C.K. Krishnan as the Chief Financial Officer [CFO] of the Company w.e.f. March 31, 2015.
Feb 2015
3 Feb · Board meeting
To transact the following business: To take on record the Unaudited (Provisional) Financial Results for the Quarter ended December 31, 2014 along with Limited Review Report. Any other matter with the permission of the Chair.
Nov 2014
14 Nov · Management
Mr. Nirmal Kumar was appointed as the Company Secretary and Compliance Officer of the Company.3 Nov · Board meeting
Meeting of the Board of Directors of the Company will be held on November 14, 2014 to transact the following business: 1. To take on record the Unaudited (Provisional) Financial Results for the Quarter and Half Year ended September 30, 2014 along with Limited Review Report. 2. Any other matter with the permission of the Chair.
Sep 2014
8 Sep · Meeting
Register of Members and Share Transfer Books of the Company will remain closed from September 25, 2014 to September 30, 2014 (both days inclusive) for the purpose of Annual General Meeting of the Company scheduled to be held on September 30, 2014.
Aug 2014
1 Aug · Board meeting
Meeting of the Board of Directors of the Company will be held on August 14, 2014, inter alia: 1. To take on record the Unaudited (Provisional) Financial Results for the Quarter ended June 30, 2014. 2. To adopt and approve the Notice and Directors' Report of the Company along with the Corporate Governance Report for financial year 2013-2014; 3. To finalize the dates of Book Closure for the purpose of forthcoming 22nd Annual General Meeting; 4. To finalize the date venue and time for convening 22nd Annual General Meeting of the Members of the Company; 5. To consider appointment of Scrutinizer to oversee the e-voting process of the Company at the 22nd Annual General Meeting. Further, as per the Company's Code of Conduct for Prohibition of insider Trading, framed pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 1992, the Trading window for dealing in the securities of the Company will be closed for the purpose of declaration of financial results of the Company for the Quarter ended June 30, 2014 from August 01, 2014 to August 14, 2014. Accordingly, all the Designated Employees (including Directors) of the Company have been intimated not to enter into any transaction involving the securities of the Company during the aforesaid period of closure of trading window.
Jun 2014
2 Jun · Board meeting
May 2014
20 May · Board meeting
(1) To consider and approve the Audited Financial Results of the Company for the year ended March 31, 2014; (2) To consider constitution of various committees, if any, of the Company. (3) Any other matter with permission of the Chair. Further, as per the Company's Code of Conduct for Prohibition of Insider Trading, framed pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 1992, the trading window for dealing in the securities of the Company will be closed for the purpose of declaration of financial results of the Company for the year ended March 31, 2014 from May 20, 2014 to May 31, 2014.
Feb 2014
4 Feb · Board meeting
To transact the following business : (1) To take on record the Unaudited (Provisional) Financial Results for the Quarter ended December 31, 2013 along with Limited Review Report; (2) Any other matter with the permission of the Chair.
Jan 2014
Nov 2013
3 Nov · Board meeting
To transact the following business : (1) To take on record the Unaudited (Provisional) Financial Results for the Quarter ended September 30, 2013 along with Limited Review Report; (2) Any other matter with the permission of the Chair.
Oct 2013
17 Oct · Board meeting
1) To consider investment in other Body Corporate pursuant to all applicable provisions of the Companies Act 1956. 2) Any other matter with the permission of the Chair.17 Oct · Board meeting
Board of Directors of the Company at its Adjourned meeting held on October 17, 2013, has decided to appoint Mrs. Mira Mehta and Mr. Deepu Kesavan Panankattil as Additional Directors on Board of the Company.14 Oct · Board meeting
Company had informed the Exchange regarding the meeting of the Board of Directors of the Company scheduled to be held on October 09, 2013 (1) To consider appointment of Additional Director(s) on Board of the Company; (2) Any other matter with the permission of the Chair. The Company has now informed the Exchange that the aforesaid Board Meeting has been rescheduled to October 17, 2013.Not held on this date
7 Oct · Board meeting
(1) To consider appointment of Additional Director(s) on Board of the Company; (2) Any other matter with the permission of the Chair.
Aug 2013
19 Aug · Board meeting
Board of Directors of the Company at its meeting held on August 14, 2013 has: (1) Approved to make investments in other Body Corporate which shall not exceed 60% of the aggregate of the paid-up share capital and free reserves and/or 100% of the aggregate of free reserves of the Company as per the limits prescribed under Section 372A of the Companies Act, 1956. (2) Approved the amendment in the Memorandum of Association of the Company by way of insertion of new Main Object Clause bearing No. 1A in PART Ill A of Memorandum of Association of the Company, after the existing Main Object Clause No. 1. (3) Approved and finalized the Notice of Postal Ballot under Section 192A of the Companies Act, 1956 for making investment in other Body Corporate pursuant to Section 372A and amendment in the Memorandum of Association of the Company pursuant to Section 17 of the Companies Act, 1956. (4) Authorized Mr. Mukund Mehta, Managing Director of the Company, to oversee the entire Postal Ballot Process, as aforesaid. (5) Appointed Mr. Deep Shukla, Practicing Company Secretary as a Scrutinizer to conduct the Postal Ballot process and to submit the Report to the Board of Directors for declaration of the results. (6) Other Matters: Board of directors made a note of letter received from statutory auditor M/s. R N R lyer and Co not seeking reappointment at ensuing AGM and hence the board of directors recommended the appointment of M/s. A.M. Ghelani & Co., Chartered Accountants, as the new Statutory Auditors of the Company for the F.Y.2013-2014, subject to the approval of the Members of the Company at the ensuing Annual General Meeting.19 Aug · Meeting
Company has fixed Book Closure from September 26, 2013 to September 30, 2013 (both days inclusive) for the purpose of Annual General Meeting of the Company to be held on September 30, 2013.2 Aug · Board meeting
Inter alia : (1) To take on record the Unaudited (Provisional) Financial Results for the Quarter ended June 30, 2013. (2) To adopt and approve the Notice and Directors Report of the Company along with the Corporate Governance Report for financial year 2012-2013. (3) To finalize the dates of Book Closure for the purpose of forthcoming Annual General Meeting. (4) To finalize the date, venue and time for convening 21st Annual General Meeting of the Members of the Company. (5) To consider investment in other Body Corporate pursuant to all applicable provisions of the Companies Act, 1956. (6) To consider amendment in Object Clause, of the Memorandum of Association of the Company. (7) To consider conducting Postal Ballot of the Company for the matters mentioned in Point Nos. 5 & 6 above pursuant to Section 192A of the Companies Act, 1956 and to finalize the Notice of Postal Ballot for the same. (8) To consider appointment of Scrutinizer to oversee the Postal Ballot process of the Company.
May 2013
17 May · Board meeting
(1) To consider and approve the Audited Accounts of the Company for the year ended March 31, 2013; (2) Any other matter with the permission of the Chair.
Feb 2013
6 Feb · Demise
Due to sad demise, Mr. Prataprai Mehta ceased to be the Chairman and Director of the Company w.e.f. February 01, 2013.
Jan 2013
30 Jan · Board meeting
To transact the following business : (1) To take on record the Unaudited (Provisional) Financial Results for the Quarter ended December 31, 2012 along with Limited Review Report; (2) Any other matter with the permission of the Chair.15 Jan · Board meeting
Board of Directors of the Company at its meeting held on January 15, 2013 has decided to disinvest Company's entire stake held in Eye Kare Kilitch Limited, being a non-listed Company, as the Board of Directors do not envisage any increase in growth on the said investment without any additional infusion of funds, which the Board do not find it feasible.14 Jan · Board meeting
(1) To consider sale of investments made by the Company. (2) Any other matter with the permission of the Chair.
Nov 2012
Oct 2012
26 Oct · Board meeting
To transact the following business : (1) To take on record the Unaudited (Provisional) Financial Results for the Quarter ended September 30, 2012 along with Limited Review Report; (2) Any other matter with the permission of the Chair.
Sep 2012